Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for RSV Clinical Trials
RSV clinical trials are recruiting across 61 cities. Here are the cities with the most active studies:
RSV Trial Phases
14 research organizations are sponsoring rsv trials.
About RSV
Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms but can be serious in infants, older adults, and immunocompromised individuals. New preventive therapies including monoclonal antibodies and vaccines have recently been approved. Clinical trials continue to investigate improved treatments.
Clinical trials are advancing new treatments for rsv. Currently, 15 studies are recruiting a combined 11,817 participants across the United States. Research is being conducted by 14 organizations including Yale University, CorEvitas, GlaxoSmithKline and 11 others.
2026 RSV Research Landscape
As of July 2026, the rsv clinical trial landscape includes 15 actively recruiting studies across 61 cities in the United States. These studies are collectively seeking 11,817 participants, with an average enrollment target of 788 per study.
The research spans multiple phases of development: 7 studies are in PHASE2, 3 studies are in PHASE1, 2 studies are in NA, 2 studies are in PHASE3, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some rsv treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 14 different organizations, including Yale University, CorEvitas, GlaxoSmithKline, DiaSorin Molecular LLC, University of California, San Francisco, and 9 others. The large number of sponsors reflects significant research interest and investment in rsv treatment advancement.
Geographically, rsv trials are most concentrated in New Haven, Connecticut (2 trials); Seattle, Washington (2 trials); Pittsburgh, Pennsylvania (2 trials); San Francisco, California (2 trials); Birmingham, Alabama (2 trials) and 7 other cities.
Featured RSV Studies
Highlighted recruiting studies for rsv, selected by enrollment size and research scope.
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
The purpose of this study is to continue evaluating how well the RSV vaccines work as they are currently being used in routine clinical practice. Some of the questions that the investigators hope to answer with this study are: 1) What is the overall effectiveness of these vaccines? 2) How long does immunity last? 3) How effective are the vaccines against new strains? 3) Does the vaccine's effectiv...
RSV Vaccine Pregnancy Registry
The research question is: What is the risk of adverse pregnancy outcomes, including preterm birth, hypertensive disorders, and other maternal and neonatal/infant outcomes, following exposure to RSV vaccine between 32 weeks, 0 days and 36 weeks, 6 days of gestation in the CorEvitas Respiratory Syncytial Virus Vaccine Pregnancy Registry (RSV-PR)? The primary study objective is to estimate the risk o...
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
The aim of this study is to evaluate the safety, reactogenicity, and immune response of the different formulations of the investigational RSV/hMPV combination vaccine and investigational hMPV vaccine in younger and older adults.
Frequently Asked Questions About RSV Clinical Trials
Are there rsv clinical trials near me?
Yes, there are 15 rsv clinical trials currently recruiting across 61+ cities in the United States, including New Haven, Connecticut; Seattle, Washington; Pittsburgh, Pennsylvania. Browse the studies above to find one at a location convenient for you.
How do I join a rsv clinical trial?
To join a rsv clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are rsv clinical trials free?
Yes, participation in rsv clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of rsv treatments are being studied?
Current rsv clinical trials are testing a range of approaches across PHASE2 (7 studies), PHASE1 (3 studies), NA (2 studies), PHASE3 (2 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 14 research organizations.
Is it safe to participate in rsv clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov